Long survival of a patient with leptomeningeal infiltration in breast cancer: A case report
Prognosis remains poor in patients with leptomeningeal carcinoma. The time from diagnosis to death is about 4–6 weeks if left untreated. With treatment, the overall survival is approximately 2–4 months.
Main Author: | Al-Bairmany Yaala Saady Raof |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-04-01
|
Series: | Forum of Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/fco-2023-0013 |
Similar Items
-
Radiotherapy for Leptomeningeal Carcinomatosis in Breast Cancer Patients: A Narrative Review
by: Ewa Pawłowska, et al.
Published: (2022-08-01) -
A case report of prostate cancer with leptomeningeal metastasis
by: Mansoureh Dehghani, et al.
Published: (2022-08-01) -
Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms
by: Leonidas Apostolidis, et al.
Published: (2021-03-01) -
Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment
by: Julian Steininger, et al.
Published: (2023-07-01) -
Menenjit ile karışan mide adenokarsinomuna bağlı leptomeningeal karsinomatozis
by: Mahmut Sünnetçioğlu, et al.
Published: (2019-12-01)